000 | 01262 a2200325 4500 | ||
---|---|---|---|
005 | 20250513203115.0 | ||
264 | 0 | _c20000303 | |
008 | 200003s 0 0 eng d | ||
022 | _a0025-7125 | ||
024 | 7 |
_a10.1016/s0025-7125(05)70212-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBhatt, D L | |
245 | 0 | 0 |
_aAntiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease. _h[electronic resource] |
260 |
_bThe Medical clinics of North America _cJan 2000 |
||
300 |
_a163-79, ix p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aAspirin _xadministration & dosage |
650 | 0 | 4 | _aClopidogrel |
650 | 0 | 4 |
_aCoronary Disease _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xprevention & control |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTopol, E J | |
773 | 0 |
_tThe Medical clinics of North America _gvol. 84 _gno. 1 _gp. 163-79, ix |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-7125(05)70212-1 _zAvailable from publisher's website |
999 |
_c10639412 _d10639412 |